Jiangsu vcare pharmaceutical technology co., LTD
Jiangsu vcare pharmaceutical technology co., LTD
Explore linked clinical trials.12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo | Non-Segmental Vitiligo | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-18 | NCT07828639 | |
| Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects | Healthy Adult Participants | Not yet recruiting | Phase 1 | 2026-09-01 | NCT07796191 | |
| Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata | Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 2 | 2026-08-27 | NCT07749716 | |
| A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata | Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Phase 1 | 2026-08-13 | NCT07762443 | |
| A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases | Pain in Bone Metastases | Not yet recruiting | Phase 1 | 2026-07-28 | NCT07731685 | |
| Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis | Moderate to Severe Atopic Dermatitis | Recruiting | Phase 3 | 2026-07-27 | NCT06723080 | |
| Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors | Locally Advanced Solid Tumor | Recruiting | Phase 3 | 2026-07-27 | NCT06658353 | |
| Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | acute coronary syndrome, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Phase 3 | 2026-07-27 | NCT06577519 | |
| A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 2 | 2026-07-07 | NCT07598383 | |
| Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 3 | 2026-07-07 | NCT07592585 | |
| Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. | Active Ankylosing Spondylitis | Recruiting | Phase 3 | 2026-01-02 | NCT07172360 | |
| Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo | Non-segmental Vitiligo | Recruiting | Phase 2 | 2026-01-02 | NCT07172347 |